HomeDNLI • NASDAQ
add
Denali Therapeutics Inc
Previous close
$18.46
Day range
$18.28 - $19.17
Year range
$14.56 - $33.31
Market cap
2.65B USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 25.24M | -7.02% |
Net income | -101.80M | 7.27% |
Net profit margin | — | — |
Earnings per share | -0.78 | 2.66% |
EBITDA | -130.09M | -17.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 936.87M | -27.29% |
Total assets | 1.58B | 12.19% |
Total liabilities | 125.62M | -71.62% |
Total equity | 1.46B | — |
Shares outstanding | 142.61M | — |
Price to book | 1.81 | — |
Return on assets | -24.18% | — |
Return on capital | -25.54% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -101.80M | 7.27% |
Cash from operations | -113.62M | -93.22% |
Cash from investing | -453.19M | -388.80% |
Cash from financing | 500.28M | 31,089.21% |
Net change in cash | -66.53M | 55.62% |
Free cash flow | -57.54M | -348.38% |
About
Founded
2013
Headquarters
Website
Employees
375